Blog

Cracking Tumor Defiance – Harvard Medical School


Harvard Medical School

Cracking Tumor Defiance
Harvard Medical School
The scientists' curiosity was piqued by the fact that ccRCC differs from other types of cancer that respond well to immunotherapy, such as melanoma, non-small cell lung cancer and a specific type of colorectal cancer. Cells of the latter cancer types

and more »

2018-01-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.